Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (171-180 of 243) with videos related to

Pageof 25
Sort By:
BJU International|February 22, 2017
Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancerErik Veskimäe, Yann Neuzillet, Mathieu Rouanne, et al.
European Urology|October 6, 2022
Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82Mark A Rubin, Mahul B Amin, Eva Compérat, et al.
Histopathology|July 27, 2019
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinomaVeronika Weyerer, Rebecca Weisser, Evgeny A Moskalev, et al.
BJU International|May 15, 2014
Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre studyGéraldine Pignot, Laurent Salomon, Cédric Lebacle, et al.
Human Pathology|June 10, 2018
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtypeUlrike Zinnall, Veronika Weyerer, Eva Compérat, et al.
World Journal of Urology|July 16, 2020
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatmentMathieu Roumiguié, Eva Compérat, Léonor Chaltiel, et al.
Diagnostics (Basel, Switzerland)|March 28, 2025
The Role of Morcellation in En Bloc Resection of Large Bladder TumorsNadav Dekel, Ekaterina Laukhtina, Andrey Morozov, et al.
Virchows Archiv : an International Journal of Pathology|February 21, 2015
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldEva Compérat, Stéphane Larré, Morgan Roupret, et al.
The Journal of Urology|January 21, 2022
<i>En Bloc</i> Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and HistopathologyTakafumi Yanagisawa, Keiichiro Mori, Reza Sari Motlagh, et al.
Histopathology|August 9, 2022
What's new in WHO fifth edition - urinary tractEva Compérat, Mahul B Amin, Dan M Berney, et al.
Pageof 25

Showing results (171-180 of 243) with videos related to

Sort By:
Pageof 25
BJU International|February 22, 2017
Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancerErik Veskimäe, Yann Neuzillet, Mathieu Rouanne, et al.
European Urology|October 6, 2022
Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82Mark A Rubin, Mahul B Amin, Eva Compérat, et al.
Histopathology|July 27, 2019
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinomaVeronika Weyerer, Rebecca Weisser, Evgeny A Moskalev, et al.
BJU International|May 15, 2014
Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre studyGéraldine Pignot, Laurent Salomon, Cédric Lebacle, et al.
Human Pathology|June 10, 2018
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtypeUlrike Zinnall, Veronika Weyerer, Eva Compérat, et al.
World Journal of Urology|July 16, 2020
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatmentMathieu Roumiguié, Eva Compérat, Léonor Chaltiel, et al.
Diagnostics (Basel, Switzerland)|March 28, 2025
The Role of Morcellation in En Bloc Resection of Large Bladder TumorsNadav Dekel, Ekaterina Laukhtina, Andrey Morozov, et al.
Virchows Archiv : an International Journal of Pathology|February 21, 2015
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldEva Compérat, Stéphane Larré, Morgan Roupret, et al.
The Journal of Urology|January 21, 2022
<i>En Bloc</i> Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and HistopathologyTakafumi Yanagisawa, Keiichiro Mori, Reza Sari Motlagh, et al.
Histopathology|August 9, 2022
What's new in WHO fifth edition - urinary tractEva Compérat, Mahul B Amin, Dan M Berney, et al.
Pageof 25